Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Stage”

3,094 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,094 results

Not applicableActive Not RecruitingNCT01411345
What this trial is testing

MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Miami 37
Testing effectiveness (Phase 2)Ended earlyNCT02648919
What this trial is testing

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Hawaii 6
Not applicableUnknownNCT01938339
What this trial is testing

Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentStage II Prostate CarcinomaStage III Prostate Carcinoma
Seoul National University Hospital 60
Not applicableActive Not RecruitingNCT03234556
What this trial is testing

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

Who this might be right for
Health Status UnknownElevated PSA
University of Southern California 288
Not applicableUnknownNCT05430737
What this trial is testing

A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer

Who this might be right for
Prostate CancerStereotactic Body RadiotherapyHigh-risk+2 more
West China Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT02607228
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Metastatic Castrate-Resistant Prostate Cancer
Gilead Sciences 31
Testing effectiveness (Phase 2)Study completedNCT00333502
What this trial is testing

Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

Who this might be right for
CancerSolid Tumor
NewLink Genetics Corporation 62
Not applicableStudy completedNCT01366053
What this trial is testing

Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists

Who this might be right for
Prostate Cancer
CMX Research 125
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing

Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277
Testing effectiveness (Phase 2)Active Not RecruitingNCT03753334
What this trial is testing

Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 39
Early research (Phase 1)Ended earlyNCT01262664
What this trial is testing

A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Looking for participantsNCT06992232
What this trial is testing

Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC

Who this might be right for
Prostate Cancer Metastatic Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 144
Testing effectiveness (Phase 2)Study completedNCT01750398
What this trial is testing

Bipolar Androgen-based Therapy for Prostate Cancer (BAT)

Who this might be right for
Recurrent Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07224009
What this trial is testing

Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)

Who this might be right for
Metastatic Prostate Cancer
University of Arkansas 60
Testing effectiveness (Phase 2)Looking for participantsNCT07192614
What this trial is testing

Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AstraZeneca 52
Not applicableEnded earlyNCT00288106
What this trial is testing

S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT

Who this might be right for
Prostate Cancer
SWOG Cancer Research Network 961
Not applicableUnknownNCT01801852
What this trial is testing

Autologous Natural Killer T Cells Infusion for the Treatment of Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Chinese PLA General Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00284752
What this trial is testing

Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Kaiser Permanente 56
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Load More Results